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Background: Since the introduction of uncemented hip implants, there has been a search for the best surface
coating to enhance bone apposition in order to improve retention. The surface coating of the different stems varies
between products. The aim was to assess the retention force and bone adaption in two differently coated stems in
a weight-bearing goat model.
Materials and methods: Hydroxyapatite (HA) and electrochemically deposited calcium phosphate (CP; Bonit®) on
geometrically comparable titanium-based femoral stems were implanted into 12 (CP group) and 35 (HA group)
goats. The animal model included physiological loading of the implants for 6 months. The pull-out force of the
stems was measured, and bone apposition was microscopically evaluated.
Results: After exclusion criteria were applied, the number of available goats was 4 in the CP group and 11 in the
HA group. The CP-coated stems had significantly lower retention forces compared with the HA-coated ones
after 6 months (CP median 47 N, HA median 1,696 N, p = 0.003). Bone sections revealed a lower degree of bone
apposition in the CP-coated stems, with more connective tissue in the bone/implant interface compared with
the HA group.
Conclusion: In this study, HA had better bone apposition and needed greater pull-out force in loaded implants.
The application of CP on the loaded titanium surface to enhance the apposition of bone is questioned.
Keywords: Hydroxyapatite, Calcium phosphate, Loaded animal model, Hip replacement, Implant stabilityIntroduction
Total hip arthroplasty (THA) is one of the most fre-
quently performed procedures in orthopaedic surgery
with more than 7,000 THAs performed each year in
Norway alone [1]. Cemented prostheses, hybrid implants
(a cemented cup and an uncemented stem) and
entirely uncemented implants are increasingly being
used. Uncemented implants pose a higher risk for revi-
sion than cemented stems [2–4] and as such may
represent additional health burden for patients. For
uncemented stems, several factors have been attributed
to stem failure and the need for revision, including an
increasing rate of infection [5], aseptic loosening and* Correspondence: knut@harboe.org
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unless otherwise stated.recurrent dislocations [1,6,7]. To overcome the com-
plications, several solutions of improvement have been
suggested. Among these are the investigations into
different geometric surface structures [8] or search for
the optimal surface coating of stems. The aims of such
investigation are to enhance bone apposition and improve
the retention force and, consequently, the longevity of the
implants [1,9,10].
The surface coatings of different stems usually include
forms of hydroxyapatite to enhance the apposition of
bone [1,11]. A previous study reported on a novel stem
design that was well fixed in a goat model [12]. The im-
plant was made from titanium alloy with hydroxyapatite
coating. The stem was designed to facilitate removal in
the event of stem failure and the need for revision sur-
gery. A previous version of the same stem design was
made from the same titanium alloy but was surfaceLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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current study was to evaluate the difference in retention
force and morphology of tissue between femoral stems
having two different resorbable coatings.
Materials and methods
The study was performed on goats receiving hip im-
plants and subjected to their natural environment in-
volving physiological loading. The goats were separated
into two different groups for evaluation, depending on
the type of coated stem implants received: either the cal-
cium phosphate (CP group) or the hydroxyapatite (HA
group) coated stems. The novel stem design and animal
care have previously been reported in detail [12], and
the two groups were part of an innovative process to
find the optimal design and surface treatment of the
final implant.
In the CP group (Figure 1), 12 adult female goats,
weighing on average 50 (38–58) kg, were admitted to
the Vivarium facility, University of Bergen, 2 weeks be-
fore surgery. This first study was a pilot with a limited
number of goats. They were clinically examined and
blood samples were analysed. They had been vaccinated
against paratuberculosis (Mycobacterium avium subspe-
cies paratuberculosis) as kids.
In the HA group, 35 adult female goats, weighing on
average 50 (40–65) kg, were admitted to the Norwegian
School of Veterinary Science, Section for Small Ruminant
Research and Farm Animal Health, Sandnes, 4 months be-
fore surgery. The number of goats was increased as theFigure 1 Design of the study. Design of the study comparing hydroxya
in a goat model.funding after the pilot study had increased, and the new site
was selected to allow this increased number. They were
clinically examined and checked for intestinal and lung
parasites by a veterinary surgeon, treated against para-
sites (Panacur, Intervet, Boxmeer, The Netherlands)
and vaccinated against clostridial diseases (Ovivac P
vet, Intervet, Boxmeer, The Netherlands). All were
clinically healthy and none had signs of caprine arth-
ritis encephalitis (CAE), which has a low prevalence in
this area of Norway. Serological test for CAE was, how-
ever, not performed. They had all been vaccinated
against paratuberculosis as kids.
The studies were approved by the Norwegian Animal
Research Authority (Reference number 2006350 and 07/
82783). The animals were euthanized if they luxated a
hip, fractured a limb or developed an infection that did
not respond to antibiotics within 14 days.
Anaesthesia was induced with xylazine (Rompun vet.,
Bayer, Berlin, Germany) 0.2 mg/kg i.m. and ketamine
(Ketalar, Pfizer, New York, NY, USA) 11 mg/kg and
maintained with isoflurane 4% and morphine 2 mg/kg
i.v. every 2 h during surgery. A ventricular drain,
coupled to a closed bag, was introduced into the womb
to relieve gas produced there.
All goats received a total hip arthroplasty using unce-
mented femoral stems of own design, combined with a
cemented canine acetabular cup and a modular head.
The operative procedure, the basic stem coated with cal-
cium phosphate and overall logistics were introduced in
2006 for the CP group. Later, stems with an updatedpatite and calcium phosphate coating of an experimental hip stem
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inserted in 2008 (HA group).
Both groups received the same novel stem design [12].
Briefly, based on preoperative radiographs of goat's
femora, a stem was produced with standard Computer
Numerical Control (CNC) technology (Aarbakke Inc.,
Bryne, Norway) and made from titanium alloy (Ti6Al4V
grade 5) in both groups. The stem in the CP group was
one size, measuring 70 mm in length. The stem had two
semicircular longitudinal grooves. The stems were grit
blasted to a roughness (Ra) of 1.5 μm, and porous com-
mercially pure titanium (titanium plasma spray (TPS),
DOT GmbH, Rostock, Germany) was added to the
grooves by vacuum plasma spraying; porosity was 21%
and pore size approximately 40 μm. The area outside
the groove was not covered with TPS. The coated stem
had no transverse canals from groove to groove. Finally,
the whole stem beneath the collar was coated with cal-
cium phosphate, with a thickness of 15–20 μm (Bonit®,
DOT GmbH, Rostock, Germany) (Figure 2).
In the HA group, there were two stem widths to accom-
modate different femoral sizes in the goat population, both
measuring 70 mm in length. The stems also had two semi-
circular longitudinal grooves, and these were connected
with 69 transverse canals measuring 1 mm in diameter.
The stems were grit blasted to a roughness (Ra) of 3–7 μm
in the proximal half and the full length of the grooves.
Hydroxyapatite (Sulzer Metco F6264, Zurich, Switzerland)
was applied all over the blasted area. The coating was ap-
proximately 80 μm thick and applied by plasma spraying
(Sulzer Metco, Zurich, Switzerland) with a porosity of <5%Figure 2 Descriptive details and design of the study implants. (A) Fro
phosphate-coated area, CP + TPS calcium phosphate on porous commercia
top views. Note on top view that the grooves are more than 180° to preve
hydroxyapatite-coated area, D drill bit, G groove. Transverse canals are 1 mand crystallinity of approximately 67% (Figure 2). This coat-
ing was chosen because of its properties similar to those of
the coating of the Corail AMT stem (DePuy, Warsaw, IN,
USA).
All stems were gamma sterilized and packed (Gamma
Service GmbH, Dresden, Germany, in the CP group and
Früh, Zurich, Switzerland, in the HA group) before use.
In both groups, a standard 17-mm total hip arthroplasty
head designed for canine use and a corresponding cemen-
ted socket (HDP, Biometrix, Boonton, NJ, USA) were used.
Both groups where operated according to the procedure
described previously [12].
Post-operative radiographs were taken before recovery
from anaesthesia. A dose of atipamezole hydrochloride,
average 0.75 mg (0–2 mg) (Antisedan Orion, Espoo,
Finland), and cefalotin 1 g i.m. was given every 3 h for
9 h (Cefalotin, ACS Dobfar Generics, Luxembourg City,
Luxembourg). To prevent hip dislocation, the animals were
retained individually in a specially tailored support sling for
three post-operative days allowing full weight bearing [13].
During this period, the animals received buprenor-
phine (Temgesic, Schering-Plough, Kenilworth, NJ,
USA) 5 μg/kg s.c. twice a day for pain relief. The ani-
mals were kept in a separate stable with one or two
other animals for an additional 2–3 days with no re-
strictions before joining other operated animals, which
were kept in a common stable until transfer. In the CP
group, the goats were transported to a local farm for
the duration of the study period. The goats were kept
indoors during the winter. In the HA group, 4 weeks
after the last animal was operated on, they were all letnt, side and top views. Far right, stem with drill bit. CP-TPS calcium
lly pure titanium in groove, D drill bit, G groove. (B) Front, side and
nt the drill bit from going astray. Far right, stem with drill bit. HA
m in diameter. (Reproduced with permission from VCOT [12]).
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and shelter.
In the CP group, the gait of the goats was scored every
4 weeks combined with weighing. In the HA group, we
scored the gait every 14 days and weighed every 4 weeks.
In both studies, the goats were scored with a modified
de Waal score [12] and clinically examined by a veterin-
arian when indicated.
The goats were euthanized with a standard bolt gun
and exsanguination (CP group) or with a bolus of 2 g of
pentobarbital intravenously (Pentobarbital, NAF, Ås,
Norway) (HA group). The left femur and ipsilateral part
of the pelvis were explanted with the prosthetic compo-
nents in situ. The specimens were kept on ice until bio-
mechanically tested the next morning.
All stems were allocated into two subgroups by coin
toss: drilled (D) and non-drilled (ND), in both studies.
All tissue in the grooves was removed by a 4.5-mm drill
bit in the drilled subgroup. The studies were approved
by the Norwegian Animal Research Authority (Reference
number 2006350 and 07/82783).
The stems were pulled out by a servo-hydraulic uni-
versal test machine (MTS 810, Minneapolis, MN, USA)
using a cross-head speed of 0.25 mm/s with continuous
sampling of the load and displacement data. The speci-
mens were fixed to the test machine by embedding the
distal part of the femur in acrylic cement (Meliodent,
Heraeus-Kulzer GmbH, Hanau, Germany) in a custom-
made steel cylinder that allowed alignment. The stem
was fixed to the cross-head by a rod that fitted threads
in the prosthesis. The testing took place at room
temperature, keeping the specimens moist throughout
the procedure [14].
To test the effect of the bonding of the coatings to the
bone, we compared the subgroups from both studies
that had the longitudinal grooves on each side drilled
(subgroup D). In this way, we minimize the difference of
the anchoring of the groove to the surrounding bone
(Figure 1).
After the biomechanical testing, the proximal part of
all femurs (above the level of acrylic cement during the
biomechanical testing) was immersed in 4% neutral
buffered formalin. Bone samples from a proximal (stem
collar), intermediate and distal (about 1 cm above the
end of the stem) part were decalcinated with ethylenedi-
aminetetraacetic acid (EDTA) demineralizing solution
(1,000 ml 4% unbuffered formalin, 75 g EDTA, 14 g
NaOH) and embedded in paraffin, cut into 2–3-μm sec-
tions and stained with hematoxylin, erythrosine, saffron
(HES) according to the laboratory protocol.
Bone apposition was evaluated by light microscopy for
bone growth and for the presence of immunological
cells, which could indicate an adverse reaction to the
coating.SPSS 19.0 (SPSS Inc., Chicago, IL, USA) was used for
data presentation and statistical analysis. Median and
range were calculated for descriptive numbers. The two
groups were compared with a non-parametric test (Mann–
Whitney) with regard to pull-out force. The significance
level was set at p < 0.05, two sided.
Results
Of the 47 goats included in the overall project, a sub-
group of 15 was available for analysis (Figure 1).
In the CP group (n = 12), one goat was euthanized due to
perioperative femoral fracture 12 days post-operatively after
being butted by another goat, and one was euthanized due
to cachexia 5 weeks post-operatively. At 6 months, two
goats were excluded due to a previous fracture that had
healed and a fissure.
In the HA group (n = 35), three goats were euthanized
due to perioperative femoral fracture, one died of cach-
exia 5 weeks post-operatively, and one was euthanized
due to an extra-articular abscess at the stifle on the op-
erated side 5 months post-operatively. Two goats man-
aged to escape the sling but were repositioned after a
short period.
In both studies, several of the goats went on butting
after being set free from the slings, i.e. after 3 days. At
autopsy 6 months post-operatively, we found one animal
in the HA group with an unacknowledged luxated hip
with a neoacetabulum above the cemented socket (this
animal had previously escaped the support sling), one
known healed reamed hole laterally in the femur, and
five loose acetabuli. These goats were also excluded from
the study (Figure 1).
After a temporary mean weight reduction for 4 weeks,
there was a mean weight gain indicating that the goats
thrived and acted normally in both groups (CP group: post-
operative 49.1 kg, 4 weeks 49.0 kg, 6 months 53.0 kg; HA
group: 51.3 kg, 48.2 kg, 55.4 kg, respectively).
In the CP group, the goats had a median gait score of
4 (range 3–5) after 4 weeks post-operatively and 4 (range
4–5) at the end of the experiment at 6 months. In the
HA group, the goats had a median gait score of 4 (range
3–5) 4 weeks post-operatively and 5 (range 3–5) at the
end of the experiment. There was no statistical differ-
ence in gait score between the CP group and the HA
group in the drilled groups (p = 0.95).
All stems were retrieved with negligible waste of peri-
prosthetic bone tissue. Stem pull-out resistance was sta-
tistically different between the drilled groups: CP group
median 47 (range 3–598) N vs. HA group median 1,696
(252–2,267) N, p = 0.003 (Figure 3).
In the CP group, there was little macroscopically
visible bone attached to the stem outside the groove.
Visually, there were no remnants of calcium phosphate.
In most stems of the HA group, bone had formed on
Figure 3 Pull-out force of study implants. Box-and-whiskers plot
of pull-out force measured in CP and HA groups. The box indicates
the 25th and 75th quartiles, with the median (bold line). The whiskers
represent minimum and maximum values. An outlier is indicated
by the circle. The difference in median was statistically significant
(**p = 0.003).
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most through holes in the grooves. The hydroxyapatite
coating was only visible as occasional small patches.
Microscopic evaluation showed scant bone towards
the stem and more connective tissue in the bone/im-
plant interface with calcium phosphate coating, whereas
abundant bone formation was seen at the hydroxyapatite
(Figure 4). There was no difference in immunoreactive
cell response.
Discussion
The results from this goat model, using titanium femoral
stems with different surfaces, demonstrate a higher reten-
tion force in favour of hydroxyapatite-coated stems com-
pared with calcium phosphate-coated stems. Of note, the
HA-coated stems were only coated in the proximal half,
while the CP-coated stems were coated all over. Assessed
by microscopy, there was a closer apposition of bone
towards the stem in the hydroxyapatite group than in the
calcium phosphate group.
Since the introduction of coated, uncemented ortho-
paedic implants, several coatings have been used toimprove their early and long-term fixation [15]. Hy-
droxyapatite is by far the most commonly used [1].
During the last decade, thinner coatings that are re-
sorbed more quickly have been developed to lower re-
sorption time and reduce the potential for scaling
[16,17]. Thus, there is a reduced foreign body reaction
and migration of particles that may cause third-body
wear [17]. Calcium phosphate is a thin coating, con-
sisting mainly of brushite, one of the most soluble
phases of calcium phosphate, which is electrochem-
ically deposited. Electrochemical deposition can coat
geometrically complex structures at room temperature,
and active substances such as antibiotics can be added
[18]. The thickness can be as low as 20 ± 10 μm and
still allows the desired bone ingrowth [19].
To our knowledge, the present large-animal experi-
mental model is unique in that it involves physiologically
loaded implants where calcium phosphate coating has
been evaluated. In a previously reported rabbit model
using unloaded implants, the use of calcium phosphate
coating increased bone ongrowth on Ti6Al4V screws
when compared with uncoated screws after 3 months of
observation [16]. The calcium phosphate coating was
similar to the one used in the present investigation.
Another study from the same group reported on unloaded
calcium phosphate- and hydroxyapatite-coated screws, with
observation times of 6, 12 and 52 weeks [20]. Screws with
calcium phosphate were coated all over, but those with hy-
droxyapatite were coated only on one side of the threads
due to line-of-sight application of coating. The data showed
removal torque force in favour of calcium phosphate, which
is in contrast to the results from the present study where
the hydroxyapatite-coated implants showed the highest re-
tention force. A further study using a cell culture model
showed coverage of newly mineralized calcium phosphate
crystals within 48 h with osteoblastic cells, and the authors
suggested a better fixation with CP in loaded models than
with hydroxyapatite [21]. However, these findings are in
contrast to the results in the present study, where physiolo-
gically loaded implants were studied after a 6-month period
of wear in a large-animal model, with conditions closely
mimicking the clinical situation. Indeed, the difference in
models may prevent from direct comparison of results.
A femoral stem using coating with calcium phosphate
(Bonit®) and TPS (Symax®, Stryker, Montreux, Switzerland)
have been used as coating since 2004 [22]. The first
study was evaluated by Einzel-Bild-Röntgen-Analyse
femoral component analysis (EBRA-FCA; a method of
measuring migration of femoral components with two
standard radiographs) and showed moderate to low
migration patterns in the stems. There have been re-
ports on good bone integration in four recovered stems
[23], and there is an ongoing randomized trial between
the Symax® stem and another hydroxyapatite-coated
Figure 4 Histological evaluation of cross-sectioned bone after stem removal. Microscopic sample from a cross section from the top third of
the stem. (A) CP group. (B) HA group. Scale is reported in millimetres.
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USA) evaluated by dual-energy X-ray absorptiometry
(DEXA) [24]. However, long-term results are not yet
available.
In our animal model, we have not analysed the mater-
ial with EBRA-FCA or DEXA and the low pull-out force
is in contrast to the apparent good osteointegration seen
in the studies of the Symax® stem. The CP coating was
applied on a base of commercially pure porous titanium,
not Ti6Al4V as in our model, which can contribute to
the good result in the Symax® stem.
Hydroxyapatite is applied to an implant by plasma spray-
ing at a high temperature in the plasma gun, leading to hightemperature at the implant (>200°C). This does not permit
temperature-sensitive additives in the coating. The coating
needs to be thicker but should be less than 80 μm to lower
the risk of scaling [17,25]. In contrast to calcium phosphate,
plasma-sprayed hydroxyapatite is applied with the line of
sight and cannot reach the inside of porous materials.
Hydroxyapatite has longer resorbing time than calcium
phosphate, which may lead to foreign body reaction [26].
We found no difference in immunoreactive cell response
by histological assessment in the current study.
It appears that hydroxyapatite enhances ingrowth in
both stable and unstable conditions [27,28], whereas cal-
cium phosphate coating is mainly studied with stable
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view that the calcium phosphate coating requires a
stable fixation to obtain osteointegration in a loaded
situation, compared with hydroxyapatite.
In the calcium phosphate group, the surface coating
with commercially pure titanium in the groove had a
pore size of 40 μm, but the aim at the design was 40–
300 μm. An optimal pore size of above 140 μm has been
suggested in other studies [29,30], in order to allow in-
growth of capillaries and possibly bone. The lack of bone
on the calcium phosphate surface might also be attrib-
uted to the small pore size.
There are methodological limitations in the present
study. The outer geometry of the two stems and the sur-
face of the grooves differ, and as such, they are not im-
mediately comparable. However, the surface area outside
the longitudinal groove is comparable, and the groove
has the same diameter, which should allow reasonable
evaluation of the bone reaction to head-to-head the
surface material. The study was not primarily designed
to investigate the difference between the coatings, and
therefore, there was no power calculation before evalu-
ation. The animals excluded for analyses reduced the
number of specimens for evaluation and could have in-
troduced a statistical bias. However, the dropouts from
the study from butting among the goats indicate that the
animals were subjected to natural behaviour and stresses
in the hip joint. The animals did have different post-
operative treatments with two separate geographical lo-
cations. However, there was no difference in weight and
gait score. Thus, the goats seemed to thrive equally well
in both facilities.
Our model is used to study implants in loaded condi-
tions, and in future application of the model, there will
be improvements with similar experimental conditions,
similar implant geometry and possibly uncoated controls
when comparing implant coatings.
Conclusion
Based on the current results of the pull-out strength and
microscopic findings, it appears that hydroxyapatite
coating of titanium-based stems provides a stronger and
more reliable retention of stems than calcium phosphate,
as revealed in this animal model involving physiological
loading for 6 months. The implications for human appli-
cations of the different coatings in hip implants should
be further evaluated.
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